drugset / Trial / NCT06453681

Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries

NCT06453681 ↗

Phase 4 Completed 60 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

the study aims to test the quality of analgesia provided by dexmedetomidine as an adjuvant to bupivacaine bilateral PECs block in patients scheduled for cardiothoracic surgeries with median sternotomy incision.

Timeline

Start
2024-08-01
Primary completion
2025-04-01
Completion
2025-05-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg —

Indications

No indication recorded.